CXCL3 was significantly overexpressed in a CD133+ sub-population within hepatocellular carcinoma, and siRNA silencing of CD133 reduced tumor weight in a mouse xenograft model and led to reduced expression of CXCL3 in vitro, demonstrating a positive correlation between the two proteins 108. This evidence concerns the gene CXCL3 and neoplasm.